CanSino Biologics, Inc. (CASBF)
3.90
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
CanSino Biologics Debt to Equity Ratio : 0.2358 for March 31, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.2358 |
| December 31, 2025 | 0.2599 |
| September 30, 2025 | 0.2891 |
| June 30, 2025 | 0.385 |
| March 31, 2025 | 0.4049 |
| December 31, 2024 | 0.411 |
| September 30, 2024 | 0.4152 |
| June 30, 2024 | 0.4341 |
| March 31, 2024 | 0.4778 |
| December 31, 2023 | 0.5147 |
| September 30, 2023 | 0.4442 |
| June 30, 2023 | 0.4204 |
| March 31, 2023 | 0.416 |
| December 31, 2022 | 0.4048 |
| September 30, 2022 | 0.3359 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.2832 |
| March 31, 2022 | 0.1968 |
| December 31, 2021 | 0.1719 |
| September 30, 2021 | 0.158 |
| June 30, 2021 | 0.1283 |
| March 31, 2021 | 0.0856 |
| December 31, 2020 | 0.0235 |
| September 30, 2020 | 0.023 |
| June 30, 2020 | 0.1122 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.1134 |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| June 30, 2018 | 0.259 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.012B |
| Total Liabilities (Quarterly) | 298.95M |
| Shareholders Equity (Quarterly) | 713.05M |
| Current Ratio | 4.107 |
| Net Debt Paydown Yield | 2.27% |